Johnson Pharmacare Limited (BOM:532154)
India · Delayed Price · Currency is INR 0.4700
+0.0100 (2.17%)
At close: Aug 14, 2026
Johnson Pharmacare Revenue
Johnson Pharmacare had revenue of 15.81M INR in the twelve months ending June 30, 2026. In the fiscal year ending March 31, 2026, Johnson Pharmacare had annual revenue of 15.81M.
Revenue
15.81M
Revenue Growth
n/a
P/S Ratio
16.35
Revenue / Employee
3.95M
Employees
4
Market Cap
258.50M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 15.81M | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 25.27M | -7.36M | -22.56% |
| Mar 31, 2022 | 32.63M | 25.03M | 329.37% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Anmol India | 12.95B |
| Sarthak Industries | 3.06B |
| Ceeta Industries | 201.87M |
| Shiva Granito Export | 117.30M |
| Ganon Products | 79.22M |
| Reetech International | 18.88M |
| Devine Impex | 18.68M |
| Landsmill Green | 16.12M |
Johnson Pharmacare News
- 2 days ago - Johnson Pharmacare Quarterly report: Q1 2027 - Filings
- 2 months ago - Johnson Pharmacare Quarterly report: Q4 2026 - Filings
- 6 months ago - Johnson Pharmacare Quarterly report: Q3 2026 - Filings
- 9 months ago - Johnson Pharmacare Quarterly report: Q2 2026 - Filings